Shukla Aseem R, Huff Dale S, Canning Douglas A, Filmer R Bruce, Snyder Howard M, Carpintieri David, Carr Michael C
Division of Urology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
J Urol. 2004 May;171(5):1900-2. doi: 10.1097/01.ju.0000120223.29924.3b.
Juvenile granulosa cell tumor (JGCT) of the testis is a rarely diagnosed subset of testicular stromal tumors. Although this variant of testicular stromal tumor is predominantly a benign entity in prepubertal patients, limited experience precludes a complete understanding of its clinical presentation and pathological diagnosis.
We reviewed all cases of testicular tumors at Children's Hospital of Philadelphia between 1976 and 2002 in males younger than 18 years. We specifically reviewed our experience with JGCT in terms of presentation, surgical treatment and long-term outcome. We also reviewed the microscopic findings and histochemical techniques used to confirm the diagnosis.
We identified 77 tumors during the defined interval, of which 3 (3.9%) were JGCTs. All 3 patients with JGCT were first noted to have a testis mass soon after birth. All presented with a firm, unilateral testicular mass. Ultrasonographic findings were consistent with a complex, multiseptated, hypoechoic mass. Two of the 3 patients underwent radical orchiectomy. Testis sparing mass excision was performed in 1 patient. Grossly the tumors were partially cystic masses. Histologically positive immunostaining with inhibin-alpha and negative staining for alpha-fetoprotein (AFP) reliably differentiated JGCTs from yolk sac tumors. At a mean followup of 8.5 years (range 5 to 14) no metastases or local tumor recurrences have been diagnosed.
To our knowledge we report the first case of testis sparing enucleation of a JGCT with a 5-year recurrence-free followup. Testis sparing enucleation is now our procedure of choice for tumors in neonates and prepubertal children with serum AFP in the normal range for age. JGCT should be suspected in neonates presenting at birth with a complex, cystic mass of the testis. Positive immunostaining for inhibin-alpha and a lack of AFP staining have consistently corroborated the pathological diagnosis in our experience and they should be applied for pediatric testis tumors that may mimic yolk sac tumor pathology.
睾丸幼年型颗粒细胞瘤(JGCT)是一种诊断较少的睾丸间质瘤亚型。尽管这种睾丸间质瘤变体在青春期前患者中主要为良性病变,但经验有限阻碍了对其临床表现和病理诊断的全面了解。
我们回顾了1976年至2002年期间费城儿童医院18岁以下男性的所有睾丸肿瘤病例。我们特别回顾了我们在JGCT的表现、手术治疗和长期预后方面的经验。我们还回顾了用于确诊的显微镜检查结果和组织化学技术。
在规定时间内我们共识别出77例肿瘤,其中3例(3.9%)为JGCT。所有3例JGCT患者在出生后不久首次被发现有睾丸肿块。所有患者均表现为单侧睾丸质地硬的肿块。超声检查结果显示为复杂的、多分隔的低回声肿块。3例患者中有2例行根治性睾丸切除术。1例患者行保留睾丸的肿块切除术。大体上肿瘤为部分囊性肿块。组织学上,抑制素-α免疫染色阳性且甲胎蛋白(AFP)染色阴性可可靠地将JGCT与卵黄囊瘤区分开来。平均随访8.5年(范围5至14年),未诊断出转移或局部肿瘤复发。
据我们所知,我们报告了首例保留睾丸摘除术治疗JGCT且随访5年无复发的病例。对于血清AFP在正常年龄范围内的新生儿和青春期前儿童的肿瘤,保留睾丸摘除术现在是我们的首选手术方法。对于出生时出现睾丸复杂囊性肿块的新生儿应怀疑JGCT。根据我们的经验,抑制素-α免疫染色阳性且缺乏AFP染色一直有助于病理诊断,它们应用于可能模仿卵黄囊瘤病理的小儿睾丸肿瘤。